An Unusual Presentation of Extramedullary Relapse Following Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

In adult patients, extramedullary relapse (EMR) in B-acute lymphoblastic leukemia (B-ALL) has a pejorative prognosis, especially after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Blinatumomab, a bispecific CD3/CD19 antibody, is approved for relapsed/refractory acute lymphoblastic...

Descripción completa

Detalles Bibliográficos
Autores principales: Daghri, Sanae, Bendari, Mounia, Belmoufid, Nadia, Yahyaoui, Anass, Ahnach, Maryame
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013240/
https://www.ncbi.nlm.nih.gov/pubmed/35449608
http://dx.doi.org/10.7759/cureus.23262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013240/
https://www.ncbi.nlm.nih.gov/pubmed/35449608
http://dx.doi.org/10.7759/cureus.23262

Ejemplares similares